09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601 3533<br />
MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
(51) (97) (54)<br />
C12N 5/06 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />
C12N 5/06 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />
COMPRISING THE SAME<br />
C12N 5/10 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />
C12N 5/10 (2006.01) EP 2<strong>09</strong>5127 * METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3,<br />
AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2<br />
C12N 5/10 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />
C12N 5/12 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />
C12N 5/12 (2006.01) EP 2<strong>09</strong>9827 * ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND<br />
TREATMENT OF NOTCH3-RELATED DISEASES<br />
C12N 5/16 (2006.01) EP 2087102 * ENHANCEMENT OF HYBRIDOMA FUSION EFFICIENCIES THROUGH CELL<br />
SYNCHRONIZATION<br />
C12N 5/18 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
C12N 5/18 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
C12N 5/18 (2006.01) EP 2<strong>09</strong>2058 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
C12N 7/02 (2006.01) EP 2087104 * MEDIUM SUPPLEMENT FOR VIRUS PRODUCTION<br />
C12N 7/04 (2006.01) EP 2<strong>09</strong>7517 * MODIFIED VACCINIA VIRUS STRAINS FOR USE IN DIAGNOSTIC AND THERAPEUTIC<br />
METHODS<br />
C12N 9/02 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />
C12N 9/04 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />
C12N 9/10 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />
C12N 9/24 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C12N 9/88 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />
C12P 21/02 (2006.01) EP 2<strong>09</strong>4726 * COMPOSITIONS AND METHODS RELATED TO TOLL-LIKE RECEPTOR-3<br />
C12P 21/02 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C12P 21/06 (2006.01) EP 2<strong>09</strong>9414 * HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING<br />
C12P 21/08 (2006.01) EP 2087002 * COMPOSITIONS AND METHODS FOR BINDING SPHINGOSINE-1-PHOSPHATE<br />
C12P 21/08 (2006.01) EP 2087103 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
C12P 21/08 (2006.01) EP 2089514 * CANCEROUS DISEASE MODIFYING ANTIBODIES<br />
C12P 21/08 (2006.01) EP 2<strong>09</strong>6122 * ANTI-HUMAN DLK-1 ANTIBODY SHOWING ANTI-TUMOR ACTIVITY IN VIVO<br />
C12P 21/08 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />
OBTAINING AND USING SAME<br />
C12P 7/06 (2006.01) EP 2<strong>09</strong>9910 * GLOBAL TRANSCRIPTION MACHINERY ENGINEERING<br />
C12P 7/16 (2006.01) EP 2<strong>09</strong>7528 * BUTANOL PRODUCTION IN A EUKARYOTIC CELL<br />
C12Q 1/00 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C12Q 1/00 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />
OBTAINING AND USING SAME<br />
C12Q 1/02 (2006.01) EP 2<strong>09</strong>8595 * HLA-A*1101-RESTRICTED WT1 PEPTIDE AND PHARMACEUTICAL COMPOSITION<br />
COMPRISING THE SAME<br />
C12Q 1/48 (2006.01) EP 2089710 * A METHOD FOR PHARMACOLOGICALLY PROFILING COMPOUNDS<br />
C12Q 1/68 (2006.01) EP 2089540 * GENETIC VARIATIONS ASSOCIATED WITH TUMORS<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>2074 * ASSESSMENT OF OOCYTE COMPETENCE<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>2079 * PHOTOGRAPIC DETERMINATION OF ANALYTES<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>3297 Agents for treatment or prevention of an allergic disorder<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>4866 * DIAGNOSIS AND TREATMENT OF BREAST CANCER<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>5127 * METHODS FOR SCREENING AND TREATMENT INVOLVING THE GENES GYPC, AGPAT3,<br />
AGL, PVRL2, HMGB 3, HSDL2 AND/OR LDB2<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>7529 * METHODS OF SELECTING AND PRODUCING MODIFIED TOXINS, CONJUGATES<br />
CONTAINING MODIFIED TOXINS AND USES THEREOF<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>7539 * POLYMORPHISMS IN THE UROCORTIN 3 GENE AND THEIR ASSOCIATIONS WITH<br />
MARBLING AND SUBCUTANEOUS FAT DEPTH IN BEEF CATTLE<br />
C12Q 1/68 (2006.01) EP 2<strong>09</strong>9937 * GENETIC SUSCEPTIBILITY VARIANTS OF TYPE 2 DIABETES MELLITUS<br />
C12Q 1/70 (2006.01) EP 2<strong>09</strong>9825 * RECOMBINANT ANTIBODIES AGAINST HEPATITIS C VIRUS AND METHODS OF<br />
OBTAINING AND USING SAME<br />
C14B 17/00 (2006.01) EP 2088853 * INDIVIDUAL IDENTIFICATION AND TRANSPORT SYSTEM FOR USE IN THE HANDLING OF<br />
KILLED FURRED ANIMALS AND PELTS FROM FURRED ANIMALS<br />
C21D 1/34 (2006.01) EP 2014777 Method and device for thermal treatment of metal sheet<br />
C21D 1/673 (2006.01) EP 2014777 Method and device for thermal treatment of metal sheet<br />
C21D 9/46 (2006.01) EP 2014777 Method and device for thermal treatment of metal sheet<br />
C21D 9/46 (2006.01) EP 2020451<br />
Method of manufacturing sheets of steel with high levels of strength and ductility, and sheets<br />
produced using same<br />
C22C 38/00 (2006.01) EP 2020451<br />
Method of manufacturing sheets of steel with high levels of strength and ductility, and sheets<br />
produced using same<br />
C22C 38/04 (2006.01) EP 2020451<br />
Method of manufacturing sheets of steel with high levels of strength and ductility, and sheets<br />
produced using same<br />
ISSN 1331-2030